Evidence map›Paper›PMID 27841752›Full record

ArticleActa crystallographica. Section D, Structural biology2016

Perdeuteration, crystallization, data collection and comparison of five neutron diffraction data sets of complexes of human galectin-3C.

Francesco Manzoni, Kadhirvel Saraboji, Janina Sprenger, Rohit Kumar, Ann Louise Noresson, Ulf J Nilsson, Hakon Leffler, S Zoë Fisher, Tobias E Schrader, Andreas Ostermann and 4 more

Abstract readComparative Study
In one paragraph

Article in Acta crystallographica. Section D, Structural biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Accurate BackboneChemphyschem : a European journal of chemical physics and physical chemistry · 2020
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Francesco ManzoniBiochemistry and Structural Biology, Department of Chemistry, Lund University, S-221 00 Lund, Sweden.
Kadhirvel SarabojiBiochemistry and Structural Biology, Department of Chemistry, Lund University, S-221 00 Lund, Sweden.
Janina SprengerBiochemistry and Structural Biology, Department of Chemistry, Lund University, S-221 00 Lund, Sweden.
Rohit KumarBiochemistry and Structural Biology, Department of Chemistry, Lund University, S-221 00 Lund, Sweden.
Ann Louise NoressonCentre for Analysis and Synthesis, Department of Chemistry, Lund University, S-221 00 Lund, Sweden.
Ulf J NilssonCentre for Analysis and Synthesis, Department of Chemistry, Lund University, S-221 00 Lund, Sweden.
Hakon LefflerDepartment of Laboratory Medicine, Section MIG, Lund University, S-221 00 Lund, Sweden.
S Zoë FisherLos Alamos National Laboratory, Los Alamos, New Mexico, USA.
Tobias E SchraderJülich Centre for Neutron Science (JCNS) at Heinz Maier-Leibnitz Zentrum (MLZ), Forschungszentrum Jülich GmbH, Lichtenbergstrasse 1, 85748 Garching, Germany.
Andreas OstermannHeinz Maier-Leibnitz Zentrum (MLZ), Technische Universität München, Lichtenbergstrasse 1, 85748 Garching, Germany.
Leighton CoatesBiology and Soft Matter Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA.
Matthew P BlakeleyInstitut Laue-Langevin, 71 Avenue des Martyrs, 38000 Grenoble, France.
Esko OksanenBiochemistry and Structural Biology, Department of Chemistry, Lund University, S-221 00 Lund, Sweden.
Derek T LoganBiochemistry and Structural Biology, Department of Chemistry, Lund University, S-221 00 Lund, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Galectin-3 is an important protein in molecular signalling events involving carbohydrate recognition, and an understanding of the hydrogen-bonding patterns in the carbohydrate-binding site of its C-terminal domain (galectin-3C) is important for the development of new potent inhibitors. The authors are studying these patterns using neutron crystallography. Here, the production of perdeuterated human galectin-3C and successive improvement in crystal size by the development of a crystal-growth protocol involving feeding of the crystallization drops are described. The larger crystals resulted in improved data quality and reduced data-collection times. Furthermore, protocols for complete removal of the lactose that is necessary for the production of large crystals of apo galectin-3C suitable for neutron diffraction are described. Five data sets have been collected at three different neutron sources from galectin-3C crystals of various volumes. It was possible to merge two of these to generate an almost complete neutron data set for the galectin-3C-lactose complex. These data sets provide insights into the crystal volumes and data-collection times necessary for the same system at sources with different technologies and data-collection strategies, and these insights are applicable to other systems.

Indexed as

Blood ProteinsCrystallizationDeuteriumGalectin 3GalectinsHumansLactoseModels, MolecularNeutron DiffractionProtein ConformationBlood ProteinsDeuteriumGalectin 3GalectinsLactoseLGALS3 protein, humancrystallogenesisgalectin-3Cneutron crystallographyperdeuteration

Identifiers

PMID27841752
PMCPMC5108347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.